MedPath

Randomised trial of dopamine vs dobutamine for treatment of low systemic blood flow in very preterm infants

Phase 3
Completed
Conditions
ow systemic blood flow in preterm infants
Low systemic blood flow in preterm infants
Reproductive Health and Childbirth - Complications of newborn
Registration Number
ACTRN12607000152426
Lead Sponsor
A/Prof Nick Evans
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
45
Inclusion Criteria

Born before 30 weeks and low systemic blood flow.

Exclusion Criteria

Major intraventricular haemorrhage before intervention commences, not expected to survive.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in systemic blood flow[Measured 30 minutes after commencement of the intervention or dose change and maintained for first 24 hours after birth with repeat measures at 12 and 24 hours of age.]
Secondary Outcome Measures
NameTimeMethod
Mortality[Assessed at hospital discharge and at 1 year of ages];Intraventricular haemorrhage on serial (5,12,24 and 48 hours of age then day 7) ultrasound through the first week.[];Neurodevelopmental outcome[At 3 years of age.]
© Copyright 2025. All Rights Reserved by MedPath